With the emergence of precision medicine, estimating optimal individualized decision rules (IDRs) has attracted tremendous attentions in many scientific areas. Most existing literature has focused on finding optimal IDRs that can maximize the expected outcome for each individual. Motivated by complex individualized decision making procedures and popular conditional value at risk (CVaR) measures, we propose two new robust criteria to estimate optimal IDRs: one is to control the average lower tail of the subjects' outcomes and the other is to control the individualized lower tail of each subject's outcome. In addition to optimizing the individualized expected outcome, our proposed criteria take risks into consideration, and thus the resulting IDRs can prevent adverse events caused by the heavy lower tail of the outcome distribution. Interestingly, from the perspective of duality theory, the optimal IDR under our criteria can be interpreted as the decision rule that maximizes the "worst-case" scenario of the individualized outcome within a probability constrained set. The corresponding estimating procedures are implemented using two proposed efficient non-convex optimization algorithms, which are based on the recent developments of difference-of-convex (DC) and majorization-minimization (MM) algorithms that can be shown to converge to the sharpest stationary points of the criteria. We provide a comprehensive statistical analysis for our estimated optimal IDRs under the proposed criteria such as consistency and finite sample error bounds. Simulation studies and a real data application are used to further demonstrate the robust performance of our methods.
Introduction
Decision making is a long standing research problem in many scientific areas, ranging from engineering, management science to statistics. In the era of big data, the traditional "one fits all" decision rules are no longer ideal in many applications due to data heterogeneity. A decision rule that works for certain subjects may not necessarily work for others. Motivated by this, it is desirable to make individualized decision rules (IDRs) that map from individual characteristics into available decision assignments. Developing effective IDRs has a wide range of applications. For example, a credit card company hopes to send a special offer for each targeted customer tailoring to his/her personal needs. An epidemiologist needs to decide whether to deliver a vaccine plan to a specific region in order to prevent the spread of diseases. From the statistical perspective, the majority of literature is focused on estimating the optimal IDR that can maximize the expected outcome or minimize the expected loss for each subject. However, some effort needs to be made to ensure reasonable outcomes for subjects falling in the tail of the distributions. Risk control needs to be taken into account to prevent adverse consequences. For example, only sending a special offer to a high-risk customer with potentially the largest expected profit may end up generating bad debt expenses for credit card company. The motivation of this paper comes from the IDR problems in precision medicine, also known as personalized medicine. One of the key goals in precision medicine is to develop better preventions and treatment methods that are tailored to each individual patient.
Prior work in precision medicine is focused on estimating the optimal IDR that can maximize expected outcome for each individual. Most existing literature can be roughly divided into two categories: model based methods and direct search methods. Q-learning (Watkins (1989) , Murphy (2005) , Schulte et al. (2014) ) and A-learning (Murphy (2003) , Robins (2004) ) are two representative model based methods. Other variants include Fan et al. (2016) , Gunter et al. (2011) , etc. For direct search methods, by viewing IDR problems as a weighted classification problem, Zhao et al. (2012) proposed to use the weighted support vector machine method to estimate the optimal IDR. Following that, various types of machine learning methods were proposed, such as Liu et al. (2016) , , , Cui et al. (2017) , Tao and Wang (2016) , , Zhang et al. (2015) , Chen et al., etc. In addition, Tian et al. (2014) , Qi and Liu (2017) and Qi and Liu (2018) proposed to use regression methods to directly estimate the optimal IDR. Recently, Chen et al. (2017) proposed a general framework for identifying optimal IDRs to maximize the expected outcome.
Due to the complicated medical procedure, only targeting on the expected outcome of each patient may not be sufficient. Risk control is necessary to prevent adverse events, i.e., the heavy tail distribution of outcome. We consider a simple and motivating example to illustrate the importance of risk control, in addition to maximize the expected outcome. Figure 1 plots the conditional density of a random outcome R under two treatments 1 and −1, given the patient's gender, i.e., male or female. Each curve corresponds to a different Gaussian density curve. If we only consider the optimal IDR that maximizes the expected outcome, treatment 1 is more suitable for female while treatment −1 is better for male. However, the gain is quite little since the mean difference is only 0.1, and thus it is hard to distinguish between these two treatments given the gender information. However, if we consider the effect of variation caused by each treatment, in order to protect each person from risky scenarios, then treatment 1 is more favorable than treatment −1 for male, and similarly, treatment −1 is more preferable than treatment 1 for female. This treatment rule may be more reasonable than the previous one because we do not want to give patients unstable, and potentially high risk treatments. We will revisit this example in our numerical studies for further illustrations. Figure 1 : Plots of a motivating example. The dash and solid lines in the left plot show the probability densities of N (−0.1, 0.5) and N (0, 1) respectively. The dash and solid lines in the right plot correspond to the probability densities of N (0, 1) and N (−0.1, 0.5) respectively. In this example, male is more preferable to treatment 1, while female is more preferable to treatment −1.
Motivated by the conditional value at risk (CVaR) used extensively in finance and risk management, we propose two new criteria that consider the expected outcome and CVaR of outcome as a weighted combination to evaluate IDRs. The resulting IDR under our proposed criteria can optimize the outcome of each individual and control the risk jointly.
The main contributions of this paper can be summarized as follows:
(a) We develop two innovative approaches to directly estimate the optimal IDR that can maximize the expected outcome while simultaneously control the average or individualized lower tail of the outcome;
(b) Two novel non-convex optimization algorithms are proposed to efficiently compute the solutions with convergence guarantee of the sharpest stationary points, based on some recent developments in optimization;
(c) We develop several important theoretical properties of our proposed methods related to statistical learning theory over two functional spaces such as two different reproducing kernel Hilbert spaces.
The remainder of this paper is organized as follows. In Section 2, supplementing the previous expected-value function framework, we introduce two new criteria to estimate the optimal IDR by using the concept of CVaR in risk management. We present several properties of our proposed criteria. In Section 3, we discuss our statistical estimation procedures to compute optimal IDRs under our proposed criteria. Two novel and efficient non-convex optimization algorithms are presented by using some recent developments in majorization-minimization (MM) and difference of convex algorithms (DCA). In Section 4, we establish several important theoretical properties of our methods by making use of statistical learning theory. We demonstrate our methods via extensive simulation studies and a data application in Sections 5 and 6, respectively. We conclude the paper and discuss some potential future work in Section 7. Some technical results are provided in the supplementary materials.
Robust Criteria to Estimate Optimal IDRs
Consider a randomized clinical study in a binary-armed treatment setting. We observe each patient's covariate information: X = (X 1 , · · · , X p ) T ∈ X , where X ⊆ R p . Then each patient will receive a treatment A ∈ A = {1, −1} randomly. The outcome R ∈ R for each patient is measured after treatment. For theoretical simplicity, we assume R ∈ R is bounded. Without loss of generality, we assume that the larger R indicates the better condition a patient is in. Define π(a|x) = P[A = a|X = x] to be the probability of a patient being assigned treatment a given the covariates of this patient. This probability is assumed to be known under a randomized clinical study or needs to be estimated in an observational study by various methods, such as logistic regression. We further assume π(a|X) > 0 for X ∈ X almost surely and every a ∈ A. Furthermore, let P be the probability distribution of a random triplet (X, A, R), under which the likelihood of (X, A, R) is defined as f 0 (x)π(a|x)f 1 (r|x, a). In particular, f 0 (x) is the probability density function of X and f 1 (r|x, a) is the conditional probability density function of R given (A, X).
An IDR d is defined as a measurable function mapping from the covariate space X into the treatment space A. For any IDR d, define P d to be the probability measure where the action A follows d. Then the probability density function under P d is defined as f 0 (x)I(a = d(x))f 1 (r|x, a), where I(•) is the indicator function. For notational purpose, we let L r (T , F 1 , P d ) be the space of all measurable functions such that T ∈T |f (T )| r dP d < ∞, where F 1 is the corresponding σ-field generated by T := X × A × R.
Expected Value Function Framework
Before introducing our new criterion and methods, we first present the existing expected-value function framework used by most existing methods, such as Qian and Zhao et al. (2012) . The value function was defined in Qian and Murphy (2011) as
where the last equality is based on Radon-Nikodym theorem (Qian and Murphy (2011) ). Note that E d [c(X)] = E[c(X)] for any measurable function c(X). Based on this value function, an optimal IDR d 0 is defined as
(2)
Note that
and then as a result,
almost surely. It is observed that under the expected-value function framework, the optimal IDR is to select the treatment with the largest expected outcome among all treatments for each patient. Despite the progress of developing optimal IDRs in precision medicine, only focusing on obtaining the largest expected outcome for each individual may be too restrictive, especially in precision medicine. For example, doctors may want to know whether a treatment does the best to improve the worst scenario, in particular for a high risk patient. Without such risk consideration, this may lead to potentially severe events, such as exacerbation or hospitalization in practice. Similar concerns may happen in the credit card company, where the "best" policy should not only improve the average profit for the company, but also reduce the chance of incurring heavy loss. This motivates us to control risk exposure caused by decision rules, in addition to maximizing the expected outcome of each individual.
Conditional Value at Risk
It is natural to consider some robust metrics such as quantiles of R given X and A to measure the effect of a treatment. The corresponding optimal IDRd under the quantile can be defined as
where Q γ (P d ) = inf{α : P d [R < α] ≥ 1 − γ} and γ ∈ (0, 1), i.e., γ-quantile of P d . However, the quantile makes the optimization Problem (4) hard to solve. Note that Q γ (P d ) is also called γ-Value at Risk (VaR), an important risk measure in finance (Jorion (2001) ). In order to address the shortcomings such as the discouragement for diversification, Artzner et al. (1999) studied an alternative risk measure called Conditional Value at Risk (CVaR), also known as the expected shortfall, average value at risk or expected tail loss. Consider a random outcome Y . The γ-CVaR of Y is given by
where F Y is the corresponding probability distribution of Y . This CVaR can be interpreted as a truncated mean lower than γ-quantile of Y . As a remark, we note that Y is often referred to as a loss in the finance literature. However, here we call Y an outcome to be consistent with the IDR literature. CVaR has several nice properties such as coherence property (Artzner et al. (1999) ) and it is preferable to VaR (Sarykalin et al. (2008) ). In addition, Pflug (2000) showed that S(F Y ) ≤ Q γ (F Y ), a lower bound of γ-VaR. This implies that larger γ-CVaR of a random outcome indicates larger γ-VaR. Note that the reverse inequality does not necessarily hold. Interestingly, in addition to several nice properties related to risk measure, CVaR can be viewed as an optimal value of concave maximization by the celebrated work of Rockafellar and Uryasev (2000) , which is defined as follows:
where [t] + = max(0, t). When used in an optimization context, the CVaR-criterion is computationally much easier than the VaR-criterion. The leftmost of the optimal solution set to (6) is Q γ (F Y ) (Rockafellar and Uryasev, 2000, Theorem 1) . Such a reformulation motivates us to propose a new criterion to study the IDR problem. For related theoretical discussions about CVaR, we refer to Rockafellar and Uryasev (2002) and the references therein.
Robust Criteria for IDR Problems
In the following two subsections, we combine the existing value function framework with the concept of CVaR in order to incorporate risk control into consideration to estimate an optimal IDR.
Average Lower Tail
Motivated by the usage of CVaR, we first propose a robust criterion that combines the value function defined in (1) and the lower tail of outcome R by a weighted factor τ ∈ [0, 1]. Specifically, this combined objective is:
where 0 ≤ τ ≤ 1. Note that
Then Q γ (P d ) can be further expressed as
which can be interpreted as the average γ-quantile of R under the decision rule d. Correspondingly
] can be understood as γ-average CVaR. Then M 1 (d) in (7) can be regarded as a convex combination of the value function and the γ-average CVaR. Similar to (6), we can rewrite (7) as
Proposition 2.1. The following two statements hold:
Proof. Statement (a) is based on the result that CVaR is a lower bound of VaR (Pflug (2000) ).
For statement (b), note that M 1 (d) is increasing with respect to γ. Letting γ = 1 gives that
According to Proposition 2.1, M 1 (d) can be regarded as a lower bound of V (d). Maximizing M 1 (d) can potentially maximize V (d). Then the optimal IDR under our proposed robust criterion
The interpretation of the optimal IDR with respect to M 1 (d) is to select a treatment with the largest convex combination of the value function and the γ-average CVaR. The representation of (10) gives us a way to compute the optimal IDR d 1 and α jointly via optimizing
When τ = 0, the combined objective reduces to original value function V (d). When τ = 1, it becomes γ-average CVaR of R with respect to P d . The choice of τ will be discussed later in our numerical studies.
Individualized Lower Tails
One natural question is whether we can control the individualized γ-CVaR instead of average γ-CVaR of the outcome for subjects. Next, we propose another criterion as an extension of M 1 (d) in (10) from the average level to individualized level risk control:
where Ξ is the σ-field generated by X and P X is the corresponding probability measure. In order to understand M 2 (d), we first characterize the optimal α * in (13). Define the individualized γ-VaR as Q γ (R|X = x, A = a) := inf{α : P (R < α(X, A)|X = x, A = a) ≥ 1 − γ} and individualized γ-CVaR as CVaR γ (R|X, a) := 1 γ E[RI(R ≤ Q γ (R|X, a))|X, A = a] given X = x and A = a. The following theorem gives an explicit expression of the optimal α * by using the theory of variational analysis (Rockafellar and Wets (2009) ).
Theorem 2.1. Given any decision rule d, α * is optimal to the optimization problem in M 2 (d) if and only if α * (X) = Q γ (R|X, A = d(X)) almost surely.
Thus
According to (14), the explicit form of α * (X) in M 2 (d) can be interpreted as the individual γquantile by the decision rule d and M 2 (d) in (15) takes each individualized CVaR into consideration. We have the following proposition to further illustrate some properties of M 2 (d).
Proposition 2.2. The following two inequalities hold:
Proof. The first inequality follows the fact that any constant is an element of L 1 (X , Ξ, P X ). The second inequality is similar to (b) in Proposition 2.1.
The first inequality in Proposition 2.2 indicates that M 2 (d) improves M 1 (d) by extending α to incorporate the covariates information X. The second inequality in Proposition 2.2 justifies the conservativeness of M 2 (d) as a lower bound of V (d). In addition, since CVaR
Proposition 2.3. The optimal IDR under the criterion M 2 (d) is given by
Under M 2 (d), the optimal IDR d 2 is equivalent to choosing a treatment that has the largest convex combination of the expected outcome and the individualized γ-CVaR among all treatments. Similar to (10), we can compute α * (X) and d 2 jointly via
Although M 1 (d) can be viewed as a special case of M 2 (d) by letting α(X) to be a constant independent of X, the interpretation is substantially different and each has its own significance as a criterion in choosing an optimal decision rule.
Duality Representation
Note that both M 1 (d) and M 2 (d) involve concave maximization. Thus it would be useful to investigate the dual representation of both M 1 (d) and M 2 (d) by making use of convex duality theory in Rockafellar (1974) . To begin with, we first define the following two sets:
and
It is noted that 0 < ε 1 < 1 and ε 2 > 1. We have the following theorem that gives the dual representation of M 2 (d).
Duality representation of M 2 (d): According to the proof for duality representation of M 2 (d), we can define a conditional probability measure P W
where I ζ (·) can be interpreted as the f -divergence distance between P W |X and P d |X . Then
, where u v means that the probability measure u is absolutely continuous with respect to the probability measure v. Thus the optimal IDR can also be written as
which can be interpreted as choosing an optimal decision rule with the highest worst expected outcome within the f -divergence distance from the original distribution P d . According to our problem setting, the density under 
This gives us a natural link to distributionally robust statistical models that can evaluate a decision rule under ambiguity. Maximizing M 2 (d) over the decision rule d is equivalent to identifying an optimal IDR that is robust to the contamination of outcome R characterized by a probability constraint set.
Thus the optimal IDR can also be written as
Moreover, the probability density V with respect to P d can be written as v 0 (x)v 1 (r|x,a=d(x)) f 0 (x)f 1 (r|x,a=d(x)) by the chain rule, according to our problem setting. Therefore, we can also express M 1 (d) as
Maximizing M 1 (d) over the decision rule d is equivalent to identifying an optimal IDR that is robust to the contamination of both outcome R and covariate information X characterized by a probability constraint set.
Comparisons between M 1 (d) and M 2 (d): From a duality representation perspective, we can see M 1 (d) and M 2 (d) have substantial differences with regard to their robustness. The "minimax" sense of M 1 (d) in (21) considers the scenario where both distributions of the covariates X and outcome R are perturbed from true underlying distributions. For M 2 (d), Proposition 2.2 shows that M 2 (d) ≥ M 1 (d), which means considering individualized CVaR improves the outcome of a given decision rule d. At the same time, however, it also indicates M 2 (d) is not as conservative as M 1 (d). This can also be justified by the "minimax" representation of (20), which considers the contamination of outcome R. In the end, both M 1 (d) and M 2 (d) are more robust than the expected-value framework, i.e., V (d). Therefore M 1 (d) and M 2 (d) may have the ability to improve generalization.
Statistical Estimation and Optimization
In this section, we discuss the estimation and optimization procedures for Problems (10) and (17) respectively given observed data. Before that, we first introduce some definitions related to the algorithm convergence of non-convex optimization problems.
Let Φ : R n → R. The directional derivative of Φ at a point x ∈ R n along the direction v ∈ R n is given by
We say
For a directionally differentiable optimization problem, d-stationary points can be viewed as the first order "sharpest" ones among different kinds of stationary points including Clarke points (Pang et al. (2016) ), and the condition (23) is the least relaxed among other types of stationarity conditions. In the following subsections, we develop two algorithms to compute d-stationary points of Problems (10) and (17) respectively, which is the best we can achieve for non-convex optimization problems in practice.
Estimation of Optimal IDRs under M 1 (d)
The optimization in (10) can be further rewritten as
where D is some classes of decision rules such as the linear ones.
Consider the binary treatment setting and let d(X) = sign(f (X)). Suppose we observe independently and identically distributed data (X i , A i , R i ); i = 1, · · · , n, then we can estimate the optimal IDR via empirical approximation:
It is well known that optimization over indicator functions is NP hard. Alternatively, we can replace the 0-1 loss function by the following smooth truncated loss,
and then use a functional margin representation to express I(A i = sign(f (X i )) as I(A i f (X i ) > 0) for each i. The corresponding function plot of S(u) is shown in Figure 2 with δ = 1. From the plot, we can see that the smooth approximation S(u) 2 is very close to the 0-1 loss. The parameter δ can control the closeness of this approximation. In practice, we can simply choose δ = 1. 
where || • || is the semi-norm in H and it is used to prevent over-fitting. The estimated IDR is given byd 1 (X) = sign(f (X)). Note that Problem (26) involves a non-convex and potentially non-smooth optimization problem. Recent development in difference-of-convex (DC) optimization (Pang et al. (2016) ) motivates us to use DC programming to efficiently solve it. Note that S(u) can be expressed as a difference of convex differentiable functions:
and G (1)
The following proposition gives us a way to express (26) as a DC function.
Proposition 3.1. The following two optimization problems have the same optimal value, i.e.,
min α∈R,f ∈H
More importantly, the optimal solution sets of f to both problems are the same.
Proof. Note that for any given f , G (1) (f, α) is a convex piecewise affine function with respect to α, thus the optimal solution set α * should contain one of the knots, i.e., R 1 , · · · , R n . Then it follows that min
and correspondingly
Based on Proposition 3.1, instead of solving (26), we can equivalently solve the optimization problem in the right hand side of (29). Let
for i = 1, · · · , n and j = 1, · · · , n, and note that c ij is not necessarily nonnegative. Recall that S(u) = S 1 (u) − S 2 (u). Then we can further rewrite G (1)
where both F j (f ) and H j (f ) are convex functions with respect to f for j = 1, · · · , n. Then we can further decomposeG
as a DC function, where h j (f ) := H j (f ) + n k =j F k (f ). Note thatG (1) (f ) is a potentially nonsmooth function if there exits multiple k's such that h k (f ) = max 1≤j≤n h j (f ). As pointed by Pang et al. (2016) , traditional DC programming cannot guarantee the convergence to a d-stationary point of the optimization problem (31) and may potentially lead to nonsense points. A failure example by traditional DC programming is given in Pang et al. (2016) . Let M (f ) := {j | h j (f ) ≥ max 1≤k≤n h k (f ) − }, i.e., " -argmax" index set. Motivated by Pang et al. (2016) , we propose the following enhanced probabilistic DCA summarized in Algorithm 1 below.
Algorithm 1 Algorithm for (26) 1: Given a fixed > 0, let f (v) be the solution at the v iteration. 2: Randomly select j ∈ M (f (v) ), and compute
3: The algorithm stops when |G (1) (f (v) ) −G (1) (f (v+1) )| < κ, for some pre-specified positive constant κ.
The proof of convergence to d-stationary points by the above algorithm can be found in Pang et al. (2016) . For the computation of the subproblem (32), efficient algorithms such as quasinewton methods can be used. If we consider that f belongs to a class of linear functions, we can also compute the solution of (26) with the l 1 penalty replacing the RKHS norm. Next, we discuss how to estimate optimal IDRs under M 2 (d).
Estimation of Optimal IDRs under M 2 (d)
Similar to the previous one in Section 3.1, we can first rewrite the optimization Problem (17) as
For illustrative purposes, we consider α(X) to be a class of linear functions and use the l 1 penalty to impose sparsity on α(X). Nonlinear functions of α(X) or other types of penalties can also be implemented similarly. Then we can compute the optimal IDR d empirically via minimizing
over f ∈ H, β ∈ R p , b ∈ R jointly. The regularization term η 2 (||β|| 2 2 + b 2 ) is to avoid numerical instability, where η is a small positive number, such as 10 −3 . In what follows, we derive a convex majorant surrogate function for G (2) (f, β, b) and propose to use majorize-minimization (MM) algorithm to solve Problem (34). Note that G (2) (f, β, b) has two properties:
is Lipschitz with respect to f , β and b.
Given f (v) at the v-th iteration, we can compute the unique solution
We definẽ
Then we have the following proposition to justify the use of MM algorithm in order to solve Problem (34).
Based on Proposition 34, we summarize our MM algorithm in Algorithm 2 below.
Algorithm 2 Algorithm for (34) 1: For a given f (v) at the v iteration, compute
3: The algorithm stops till some stopping criteria of f (v) are satisfied.
Proposition 3.2 and three properties of G (2) (f, β) are the building blocks for the convergence of our proposed MM-algorithm in Table 2 to a d-stationary point. The related proof can be found in (Mairal, 2015, Example 2.3.4 ; Proposition 2.5). For recent development in MM-algorithm, see Cui et al. (2018) .
Theoretical Results
In this section, we discuss the statistical theory related to M 2 (d), while the method of controlling the average lower tail using M 1 (d) can be viewed as a special case. For simplicity, we consider the case that τ = 1 in M 2 (d), but the result can be directly generalized for other τ by combining the existing results under the expected-value function such as Zhao et al. (2012) or . We define two corresponding value functions for τ = 1 as follows:
The corresponding optimal solutions of maximizing (38) is d * = sign(f * ) and α * . Since we use the surrogate loss function S(u), we further define
as the surrogate value function. Our theoretical results are based on statistical learning theory with an extension to two functional classes, since we need to consider both f and α in our problems.
Fisher Consistency
We first establish Fisher consistency of estimating optimal ITRs under M T (f, α) to justify the use of the surrogate loss S(u), compared with M 0 (d, α) . This is different from the classical Fisher consistency, which only involves one functional class of interest. Based on Theorem 4.1, instead of M 0 (d, α), we can target on M T (d, α) alternatively.
Excess Value Bound
Based on Theorem 4.1, we can further justify the use of the surrogate function S(u) by establishing the following excess value bound for the 0-1 loss in M 0 (d, α). 
Theorem 4.2 gives us a way of bounding the difference between the optimal IDR and the estimated IDR under M 0 (d, α) by using M T (d, α) instead.
Convergence Rate
In order to obtain the finite sample performance of our estimated optimal IDR under M 0 (d, α), it is enough to focus on the difference of M T (d, α) between the estimated optimal IDR and the optimal ITR based on Theorem 4.2. Define
where
. We consider different penalty functions. In particular, || • || H i can be one of the following choices:
(1) l 1 norm of coefficients if we consider
(2) l 2 norm of coefficients if we consider
(3) RKHS norm if we consider H i ; i = 1, 2 to be RKHS with Gaussian radial basis functions.
Before presenting our results, we need following definitions.
Definition 4.1. Consider F to be a class of real value measurable functions f : Z → R. The Rademacher complexity of F is defined as
where Z 1 , · · · , Z n are drawn i.i.d from some probability distribution P and the Rademacher random variables σ 1 , · · · , σ n are drawn i.i.d from uniform distribution over {1, −1}.
If we interpret the Rademacher random variables as noise, the Rademacher complexity is the maximal correlation between functions and the pure noise. Thus it can measure the complexity of classes of functions. The corresponding empirical Rademacher complexity of F is defined aŝ
where we can see that E[R n (F)] = R n (F). The following lemma characterizes the Rademacher complexity of the Lipschitz composition operator. It is an extension of Corollary 3.17 in Ledoux and Talagrand (2013) .
Lemma 4.1. If a function φ : R p → R is Lipschitz continuous with respect to the l 1 norm, i.e
for any t i , s i . Then we have
where F i is a certain class of functions for i = 1, · · · , n.
is considered to be the approximation error. The following theorem gives us a finite sample upper bound of our estimated optimal IDR and the optimal IDR based on M 0 (d, α) by the estimation and approximation errors.
Theorem 4.3. For any distribution P over (X, A, R) such that |R| ≤ C 0 and π(a|X) ≥ a 0 a.s. for any a, then with probability 1 − , one can have
In order to obtain the finite sample bound, we need to compute the empirical Rademacher complexity of Π 1 and Π 2 and also bound the approximation error. The results will depend on the specific choice of H i for i = 1, 2. In the following, we give several corollaries in order to establish the finite sample bound for our estimated optimal IDR under M 0 (d, α). 
with ||w * || 2 2 + (b * 1 ) 2 ≤ D 1 and ||θ * || 2 2 ≤ +(b * 2 ) 2 ≤ D 2 for some constants C 1 , D 1 , D 2 , then under the assumptions in Theorem 4.3, with probability 1 − , one can have
for some constant c 1 .
Corollary 4.3.2. Consider H i to be classes of linear functions with the l 1 penalty for i = 1, 2 and suppose ||X|| ∞ ≤ C 2 . If f * T ∈ H 1 and α * T ∈ H 2 , that is f * T = X T w * + b * 1 and α * T = X T θ * + b * 2 with ||w * || 1 +|b * 1 | ≤ D 3 and ||θ * || 1 +|b * 2 | ≤ D 4 for some constants C 2 , D 3 , D 4 , then under the assumptions in Theorem 4.3, with probability 1 − , one can have
for some constant c 2 .
Corollary 4.3.3. Consider H i to be RKHS with Gaussian radial basis functions for i = 1, 2 and suppose assumptions in Theorem 4.3 hold. If A(λ 1n , λ 2n ) ≤ C 5 λ w 1 1n + C 6 λ w 2 2n , where w 1 , w 2 ∈ (0, 1], then with probability at least 1 − ,
3 ) max n 
3 .
The above corollary shows that the difference between our estimated IDRs and the optimal IDR under M 0 (d, α) converges to 0 in probability under some conditions. The upper bound assumption on the approximation error A(λ 1n , λ 2n ) is analogous to those in the statistical learning literature such as Steinwart and Scovel (2007) to derive the convergence rate.
Simulation Studies
In our numerical analysis, we set τ = 0.5 and γ = 0.5 to treat expected-value and CVaR value functions equally in most examples, while we show different performances of different τ and γ in our first simulation example below. For all simulation settings, we consider binary-armed randomized trials with equal probabilities of patients being assigned to each treatment group.
We use l1-DC-CVaR, l2-DC-CVaR and GK-DC-CVaR to represent the methods of estimating optimal IDRs under M 1 (d) with three different penalties on f in Problem (26) respectively. Here "l1" and "l2" refer to the l 1 and l 2 penalties. "GK" represents using Gaussian radial basis functions with bandwidth ς to learn the optimal IDR. Similarly, we use l1-MM-CVaR, l2-MM-CVaR and GK-MM-CVaR to represent the methods of estimating optimal IDRs under M 2 (d) with three different penalties on f in Problem (34) respectively.
All tuning parameters are selected based on the 10-fold-cross-validation procedure. We select the tuning parameter that maximizes the empirical average of mixed value functions M 1 (d) and M 2 (d) on the validation data set defined aŝ
andM
respectively, where E n denotes the empirical average over the validation data. We compare our methods with the following four methods:
(1) D-learning by Qi and Liu (2017) ;
(2) l 1 -PLS by Qian and Murphy (2011) with basis function (1, X, A, XA);
(3) RWL by with linear kernel;
(4) RWL by with Gaussian kernel.
A Motivating Example Revisit
Recall the motivating example in Figure 1 that shows the importance of risk controls in estimating optimal IDRs. In this subsection, we conduct some numerical analysis to further demonstrate this finding. In particular, the covariate of gender is generated by uniform distribution over {1, −1}, where 1 and −1 denotes male and female respectively. The corresponding outcome R is generated by the following model:
where 1 ∼ N (−0.1, 1) and 2 ∼ N (0, 0.5). We consider training data with the sample size n = 200 and independently generated test data of size 10000. We first set τ = γ = 0.5. Based on test data, in Figure 3 , we plot box plots of three different outcome distributions if treatments follow estimated IDRs by l 1 -PLS, linear RWL, l2-DC-CVaR and l2-MM-CVaR correspondingly. Based on these box plots, we can observe that since there is not much difference between these two treatments based on the expected outcome, the empirical mean of value functions resulted from these four methods are indistinguishable. However, besides maximizing the expected outcome for each individual, our methods also control the risk of each individual. Thus the resulting outcome distributions by our methods are more stable, has less variability than those of l 1 -PLS and linear RWL.
In addition, we also plot medians and standard deviations of value functions of one replication under different combinations of τ and γ by l2-DC-CVaR in Figure 4 . We can see that as τ gets close to 1 and γ gets close to 0, the standard deviations of corresponding value functions are small, which means the resulting optimal IDRs are more stable since we put more weights on lower tails. However, the corresponding medians of value functions are not large. In contrast, if we choose relatively balanced τ and γ, the medians of value functions are larger by sacrificing some stability. In practice, users can decide his or her own preferences based on the specific problem. 
Distribution Shift Examples
In this section, we demonstrate the superior performance of our methods under distribution shift of covariates X and outcome R based on the duality representations of M 1 (d) and M 2 (d) in 21 and 20 respectively. We consider the sample size n = 200 and the dimension p = 20. The outcome R is generated by the model: R = 1 + x 1 + x 2 + A(x 1 − x 2 + x 3 ) + . We consider the following two distribution shift scenarios:
(1) Each covariate follows a two component Gaussian mixture distribution of N (0, 1) and N (5, 1) with probability of mixture to be 0.8 and 0.2 respectively and follows standard Gaussian distribution;
(2) Covariates X are generated by the uniform distribution between −1 and 1 and follows a two component mixture distribution of N (0, 1) and log-normal distribution lognorm(0, 2) with probability of mixture to be 0.7 and 0.3 respectively.
The first scenario considers the covariate distribution shift and the second scenario considers the outcome distribution shift. For simplicity, we only report misclassification error rates given by l 1 -PLS, linear RWL, l2-DC-CVaR and l2-MM-CVaR in Table 1 . For Scenario (1), since l 1 -PLS assumes a linear model, it's performance is not affected by covariate distribution shift. In contrast, rwl, which is based on maximizing the value function, depends heavily on correct approximation to value function empirically. Thus the performance of rwl is worse than l 1 -PLS under this scenario. For the estimated optimal IDR under M 1 (d), the performance is superior to rwl because M 1 (d) considers the perturbation of the covariate distribution shift, while M 2 (d) does not and its corresponding performance is relatively worse. For Scenario (2), since both estimated optimal IDRs under M 1 (d) and M 2 (d) are minimax estimator under the outcome distribution shift, the performances are much better than two other methods under the value function framework. 
Simulation Scenarios
In this subsection, we further study the performance of our proposed methods via eight simulation examples. We consider the sample size n = 200 and the dimension p = 20. The covariates X are generated by the uniform distribution between −1 and 1. The outcome R is generated by the model: R = 1 + x 1 + x 2 + Aδ(X) + . We consider the following eight different combinations of δ(X) and :
(1) δ(X) = x 1 − x 2 + x 3 , and follows Gaussian normal N (0, 1);
(2) δ(X) = x 1 − x 2 + x 3 , and log( ) follows Gaussian normal N (0, 2|1 + x 1 + x 2 |);
(3) δ(X) = x 1 − x 2 + x 3 , and log( ) follows Gaussian normal N (0, 2);
(4) δ(X) = x 1 − x 2 + x 3 , and follows a Weibull distribution with shape parameter 0.3 and scale parameter 0.5;
(5) δ(X) = 3.8(0.8 − x 2 1 − x 2 2 ), and follows Gaussian normal N (0, 1);
(6) δ(X) = 3.8(0.8 − x 2 1 − x 2 2 ), and log( ) follows Gaussian normal N (0, 2|1 + x 1 + x 2 |);
(7) δ(X) = 3.8(0.8 − x 2 1 − x 2 2 ), and log( ) follows Gaussian normal N (0, 2);
(8) δ(X) = 3.8(0.8 − x 2 1 − x 2 2 ), and follows a Weibull distribution with shape parameter 0.3 and scale parameter 0.5.
We consider different shapes of error distributions to test the robustness of our methods, compared with other methods. The first four scenarios are of linear decision boundaries while the remaining four consider nonlinear decision boundaries. In order to evaluate different methods, we generate test data and use sign(δ(X)) as the true optimal decision rule, since treatment A only appears in the interaction term δ(X). We evaluate different methods based on the misclassification error rates in Table 2 , mean of expected-value functions in Table 3 , mean of 50% and 25% quantiles of value functions in Tables 4 and 5 . Overall, our methods show competitive performances among all methods. In particular, for Scenarios (1) and (5), which are standard simulation settings in IDRs literature, our proposed methods performs well in finding optimal IDRs. For Scenarios (2) and (6), the error distributions depend on the covariate information. Although the average of empirical value functions of our proposed methods are smaller than those of RWL, the 50% and 25% quantiles of empirical value functions by our methods are much better. One possible reason is that methods under the expected-value function framework ignore subjects with potentially high risk while only focusing on maximizing the expected-value function. Thus the resulting IDRs by these methods may assign wrong treatments to patients and make them become even worse by delivering the corresponding IDR. Similar observations can be drawn from other simulation scenarios. 
Real Data Applications
In this section, we perform a real data analysis to further evaluate our proposed robust criteria for estimating optimal IDRs. The clinical trial dataset we used comes from "AIDS Clinical Trials Group (ACTG) 175" in Hammer et al. (1996) to study whether there exists some subpopulations that are suitable for different combinations of treatments for AIDS. In this study, a total number of 2139 patients with HIV infection were randomly assigned into four treatment groups: zidovudine (ZDV) monotherapy, ZDV combined with didanosine (ddI), ZDV combined with zalcitabine (ZAL), and ddI monotherapy with equal probability. In this data application, we focus on finding optimal IDRs between two treatments: ZDV with ddI and ZDV with ZAL as our interest. The total number of patients receiving these two treatments are 1046.
Similar to the previous studies by Lu et al. (2013) and Fan et al. (2016) , we select 12 baseline covariates into our model: age (year), weight(kg), CD4+T cells amount at baseline, Karnofsky score (scale at 0-100), CD8 amount at baseline,gender (1 = male, 0 = female), homosexual activity (1 = yes, 0 = no), race (1 = non white, 0 = white), history of intravenous drug use (1 = yes, 0 = no), symptomatic status (1=symptomatic, 0=asymptomatic), antiretroviral history (1=experienced, 0=naive) and hemophilia (1=yes, 0=no). The first five covariates are continuous and have been scaled before estimation. The remaining seven covariates are binary categorical variables. We consider the outcome as the difference between the early stage (around 25 weeks) CD4+ T (cells/mm 3 ) cell amount and the baseline CD4+ T cells before the trial. Using this outcome, we can estimate the optimal IDR under our proposed robust criteria. To evaluate the performance of our proposed methods under robust criteria, we randomly divide the dataset into five folds and use four of them to estimate optimal IDRs by different methods. The remaining one fold of data is used to evaluate the performances of different methods. We repeat this procedure 220 times. For each method, we report the mean, 50% and 25% quantiles of empirical value functions. From Table 6 , we can see that our proposed methods perform competitively among all methods. In particular, the "GK-DC-CVaR" method performs the best compared with other methods, which indicates the optimal IDR of this problem may be potentially nonlinear. Another observation is that our proposed methods are not consistently better than other methods since robust methods are not necessarily the best for a specific application. However, robustness can be more insensitive to some deviations from model assumptions, which implies that our methods have the potential to be applied for a wide range of problems. 
Conclusion
In this paper, we propose two robust criteria to estimate optimal IDRs by considering individualized risk using the concept of CVaR. The resulting optimal IDRs can not only maximize the individualized expected outcome, but also prevent adverse consequences by controlling the lower tails of the outcome distributions.
Several possible extensions can be explored for future study. In particular, if we observe some additional risk outcome, such as side effect, for each subject, it would be interesting to develop methods to control this risk outcome under a pre-specified level by using our proposed criteria. This model was studied under the expected-value function framework given by Wang et al. (2018) . Furthermore, Wang et al. (2017) recently used quantiles of outcome as criteria to identify optimal IDRs. They proposed a doubly robust estimation method to find the optimal IDR under their proposed criteria. It would be worthwhile to compare the performance of their methods with our proposed methods. Finally, from our numerical analysis, in some scenarios, estimated IDRs under M 1 (d) are better than those under M 2 (d). One possible reason is the potential model misspecification of α * (X) given in (14), which we specify to be linear in the numerical study. Thus it would be desirable to explore broader structure of α(X) or develop some robust estimation methods to overcome potential model misspecification of α(X).
